GE HealthCare Technologies Inc. (GEHC)
After hours:
| Previous Close | 77.83 |
| Open | 78.50 |
| Bid | 72.57 x 200 |
| Ask | 85.40 x 200 |
| Day's Range | 78.50 - 80.06 |
| 52 Week Range | 62.35 - 94.50 |
| Volume | |
| Avg. Volume | 3,773,151 |
| Market Cap | 36.275B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 23.10 |
| EPS (TTM) | 3.44 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.12 (0.15%) |
| Ex-Dividend Date | Apr 18, 2024 |
| 1y Target Est | 93.71 |
- Business Wire
GE HealthCare Management to Present at Upcoming Investor Conferences
CHICAGO, May 02, 2024--GE HealthCare (Nasdaq: GEHC), is announcing that its Vice President and Chief Financial Officer, Jay Saccaro will be presenting at the following upcoming investor conferences.
Simply Wall St.GE HealthCare Technologies First Quarter 2024 Earnings: Misses Expectations
GE HealthCare Technologies ( NASDAQ:GEHC ) First Quarter 2024 Results Key Financial Results Revenue: US$4.65b (down...
Business WireGE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress
CHICAGO, May 01, 2024--GE HealthCare (Nasdaq: GEHC) today announced Revolution RT,i a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients. The new Revolution RT is being unveiled at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2024 Congress in Glasgow, a
